CIK 0000860730 · Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 273865930
- Phone
- 6153449551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-28 | Paslick P. Martin SVP and CIO | Grant or award · Stock Appreciation Right | +10,400 | 10,400 | ||
| 2022-01-28 | Mosier Sammie S SVP & Chief Nurse Executive | Grant or award · Stock Appreciation Right | +5,550 | 5,550 | ||
| 2022-01-28 | MOORE A BRUCE JR Group President - Service Line | Grant or award · Stock Appreciation Right | +12,480 | 12,480 | ||
| 2022-01-28 | McAlevey Michael R SVP & Chief Legal Officer | Grant or award · Stock Appreciation Right | +13,860 | 13,860 | ||
| 2022-01-28 | McAlevey Michael R SVP & Chief Legal Officer | Grant or award · Stock Appreciation Right | +13,170 | 13,170 | ||
| 2022-01-28 | McAlevey Michael R SVP & Chief Legal Officer | Grant or award · Restricted Stock Units | +3,880 | 3,880 | ||
| 2022-01-28 | HAZEN SAMUEL N CEO | Grant or award · Stock Appreciation Right | +86,630 | 86,630 | ||
| 2022-01-28 | Hall Charles J Group President | Grant or award · Stock Appreciation Right | +18,020 | 18,020 | ||
| 2022-01-28 | Foster Jon M Group President | Grant or award · Stock Appreciation Right | +18,020 | 18,020 | ||
| 2022-01-28 | Cuffe Michael S. EVP and Chief Clinical Officer | Grant or award · Stock Appreciation Right | +15,250 | 15,250 | ||
| 2022-01-28 | Cohen Jeffrey E. SVP-Government Relations | Grant or award · Stock Appreciation Right | +4,160 | 4,160 | ||
| 2022-01-28 | Billington Phillip G SVP-Internal Audit Services | Grant or award · Stock Appreciation Right | +4,160 | 4,160 | ||
| 2022-01-28 | Berres Jennifer SVP & Chief Human Res. Officer | Grant or award · Stock Appreciation Right | +10,400 | 10,400 | ||
| 2022-01-05 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise | +23,375 | $47.97 | $1.1M | 35,732 |
| 2022-01-05 | Sowell Joseph A III SVP; Chief Development Officer | Shares withheld for taxes | −11,853 | $258.97 | $3.1M | 23,879 |
| 2022-01-05 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise · Stock Appreciation Right | −23,375 | 0 | ||
| 2022-01-04 | Sowell Joseph A III SVP; Chief Development Officer | Sale | −22,198 | $259.23 | $5.8M | 12,357 |
| 2021-12-29 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise | +42,750 | $37.18 | $1.6M | 55,107 |
| 2021-12-29 | Sowell Joseph A III SVP; Chief Development Officer | Shares withheld for taxes | −20,552 | $258.49 | $5.3M | 34,555 |
| 2021-12-29 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise · Stock Appreciation Right | −42,750 | 0 |
Page 36 of 56 · 1,102 trades